Literature DB >> 23790210

Anomalous protein-DNA interactions behind neurological disorders.

Sergio Camero1, María J Benítez, Juan S Jiménez.   

Abstract

Aggregation, nuclear location, and nucleic acid interaction are common features shared by a number of proteins related to neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, transmissible spongiform encephalopathy, Huntington's disease, spinobulbar muscular atrophy, dentatorubro-pallidoluysian atrophy, and several spinocerebellar ataxias. β-Amyloid peptides, tau protein, α-synuclein, superoxide dismutase1, prion protein, huntingtin, atrophin1, androgen receptor, and several ataxins are proteins prone to becoming aggregated, to translocate inside cell nucleus, and to bind DNA. In this chapter, we review those common features suggesting that neurological diseases too may share a transcriptional disorder, making it an important contribution to the origin of the disease.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23790210     DOI: 10.1016/B978-0-12-411637-5.00002-0

Source DB:  PubMed          Journal:  Adv Protein Chem Struct Biol        ISSN: 1876-1623            Impact factor:   3.507


  3 in total

Review 1.  Pathological implications of nucleic acid interactions with proteins associated with neurodegenerative diseases.

Authors:  Yraima Cordeiro; Bruno Macedo; Jerson L Silva; Mariana P B Gomes
Journal:  Biophys Rev       Date:  2014-01-09

2.  The Bacterial Amyloid-Like Hfq Promotes In Vitro DNA Alignment.

Authors:  Frank Wien; Denis Martinez; Etienne Le Brun; Nykola C Jones; Søren Vrønning Hoffmann; Jehan Waeytens; Melanie Berbon; Birgit Habenstein; Véronique Arluison
Journal:  Microorganisms       Date:  2019-12-03

3.  Alpha-Synuclein Modulates the Physical Properties of DNA.

Authors:  Kai Jiang; Sandra Rocha; Alvina Westling; Sriram Kesarimangalam; Kevin D Dorfman; Pernilla Wittung-Stafshede; Fredrik Westerlund
Journal:  Chemistry       Date:  2018-09-19       Impact factor: 5.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.